Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance

Download
2007-12-01
BARAN, YUSUF
Guer, Bala
Kaya, Pelin
Ural, Ali Ugur
Avcu, Ferit
Gündüz, Ufuk
The major problem in the treatment of acute myeloid leukemia (AML) patients results from multidrug resistance to administered anticancer agents. Drug resistance proteins, MDR1 and MRP1, which work as drug efflux pumps, can mediate the multidrug resistance of human leukemia cells. In this study, the mechanisms of resistance to doxorubicin-induced cell death in human HL60 AML cells were examined.
Citation Formats
Y. BARAN, B. Guer, P. Kaya, A. U. Ural, F. Avcu, and U. Gündüz, “Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance,” pp. 511–517, 2007, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/30738.